Viral manipulation of DNA damage response signaling: Molecular mechanisms and therapeutic implications
Virologica Sinica · 2026-10 · 41 (5) · 1007-1022
DOI: 10.1016/j.virs.2026.08.014 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Virologica Sinica, 2026-10. Verfasst von Mingyue Song und 3 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Animal Pathogen Infection and Immunology of Fujian Province, College of Animal Sciences, Fujian Agriculture and Forestry University…. Hauptthemen laut MEDLINE: DNA Damage, Signal Transduction, Host-Pathogen Interactions, Virus Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 184 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Animal Pathogen Infection and Immunology of Fujian Province, College of Animal Sciences, Fujian Agriculture and Forestry University, Fuzhou 350002, China; Joint Laboratory of Animal Pathogen Prevention…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Song, M., Wang, S., Fei, X., & Guo, G. (2026). Viral manipulation of DNA damage response signaling: Molecular mechanisms and therapeutic implications. Virologica Sinica, 41(5), 1007-1022. https://doi.org/10.1016/j.virs.2026.08.014
Vancouver
Song M, Wang S, Fei X, Guo G. Viral manipulation of DNA damage response signaling: Molecular mechanisms and therapeutic implications. Virologica Sinica. 2026;41(5):1007-1022. doi:10.1016/j.virs.2026.08.014
BibTeX
@article{Song2026,
author = {Song, Mingyue and Wang, Shuyi and Fei, Xiao and Guo, Guijie},
title = {Viral manipulation of DNA damage response signaling: Molecular mechanisms and therapeutic implications},
journal = {Virologica Sinica},
year = {2026},
volume = {41},
number = {5},
pages = {1007--1022},
doi = {10.1016/j.virs.2026.08.014}
}
EUVIMED